Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP119

Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP119

Plasmodium vivax is the most widely distributed malaria species and the most prevalent species of malaria in America and Asia. Vaccine development against P. vivax is considered a priority in the global program for the eradication of malaria. Earlier studies have characterized the Apical Membrane An...

Full description

Bibliographic Details
Main Authors:	Rocha, M, Françoso, K, Lima, L, Camargo, T, Machado, R, Costa, F, Rénia, L, Nosten, F, Russell, B, Rodrigues, M, Soares, I
Format:	Journal article
Language:	English
Published:	Elsevier 2017

Similar Items

Protective Immunity in Mice Immunized With P. vivax MSP119-Based Formulations and Challenged With P. berghei Expressing PvMSP119
by: Irina Dobrescu, et al.
Published: (2020-02-01)

Safety and immunogenicity of a malaria vaccine, Plasmodium falciparum AMA-1/MSP-1 chimeric protein formulated in montanide ISA 720 in healthy adults.
by: Jinhong Hu, et al.
Published: (2008-01-01)

Antigenicity of a Bacterially Expressed Triple Chimeric Antigen of Plasmodium falciparum AARP, MSP-311 and MSP-119: PfAMSP-Fu35.
by: Aakanksha Kalra, et al.
Published: (2016-01-01)

Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3
by: Bitencourt, A, et al.
Published: (2013)

Specificity of the IgG antibody response to Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, and Plasmodium ovale MSP119 subunit proteins in multiplexed serologic assays
by: Jeffrey W. Priest, et al.
Published: (2018-11-01)

Plasmodium vivax susceptibility to ferroquine.
by: Leimanis, M, et al.
Published: (2010)

Immunogenicity of PvCyRPA, PvCelTOS and Pvs25 chimeric recombinant protein of Plasmodium vivax in murine model
by: Matos, ADS, et al.
Published: (2024)

Solution structure of a <it>Plasmodium falciparum </it>AMA-1/MSP 1 chimeric protein vaccine candidate (PfCP-2.9) for malaria
by: Jin Changwen, et al.
Published: (2010-03-01)

Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3.
by: Amanda R Bitencourt, et al.
Published: (2013-01-01)

The Immunogenic and Immunoprotective Activities of Recombinant Chimeric <i>T. gondii</i> Proteins Containing AMA1 Antigen Fragments
by: Justyna Gatkowska, et al.
Published: (2020-12-01)

Rheopathologic consequence of Plasmodium vivax rosette formation
by: Nosten, F, et al.
Published: (2016)

ama1 genes of sympatric Plasmodium vivax and P. falciparum from Venezuela differ significantly in genetic diversity and recombination frequency.
by: Rosalynn L Ord, et al.
Published: (2008-01-01)

Genetic diversity of <it>msp3α </it>and <it>msp1</it>_b5 markers of <it>Plasmodium vivax </it>in French Guiana
by: Carme Bernard, et al.
Published: (2009-03-01)

Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeast.
by: Vicentin, E, et al.
Published: (2014)

Natural infections with different Plasmodium species induce antibodies reactive to a chimeric Plasmodium vivax recombinant protein
by: Jessica N. McCaffery, et al.
Published: (2021-02-01)

A Multistage Formulation Based on Full-Length CSP and AMA-1 Ectodomain of <i>Plasmodium vivax</i> Induces High Antibody Titers and T-cells and Partially Protects Mice Challenged with a Transgenic <i>Plasmodium berghei</i> Parasite
by: Luciana C. Lima, et al.
Published: (2020-06-01)

Structural patterns of selection and diversity for Plasmodium vivax antigens DBP and AMA1
by: Andrew J. Guy, et al.
Published: (2018-05-01)

Human ex vivo studies on asexual Plasmodium vivax: The best way forward
by: Russell, B, et al.
Published: (2012)

Human ex vivo studies on asexual Plasmodium vivax: the best way forward.
by: Russell, B, et al.
Published: (2012)

Methotrexate is highly potent against pyrimethamine-resistant Plasmodium vivax.
by: Imwong, M, et al.
Published: (2011)

Unambiguous determination of Plasmodium vivax reticulocyte invasion by flow cytometry
by: Cho, J, et al.
Published: (2015)

Immunogenicity of a virosomally-formulated <it>Plasmodium falciparum </it>GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations
by: Tamborrini Marco, et al.
Published: (2011-12-01)

Advances toward the development of an asexual blood stage MSP-1 vaccine of Plasmodium vivax
by: Gabriela Levitus, et al.
Published: (1994-01-01)

Polymorphism in the Plasmodium vivax msp 3: gene in field samples from Tierralta, Colombia
by: Fabio Aníbal Cristiano, et al.
Published: (2008-08-01)

Colorimetric Detection of Plasmodium vivax in Urine Using MSP10 Oligonucleotides and Gold Nanoparticles.
by: Yossef Alnasser, et al.
Published: (2016-10-01)

Murine immune responses to a <it>Plasmodium vivax</it>-derived chimeric recombinant protein expressed in <it>Brassica napus</it>
by: Chung Nam-Jun, et al.
Published: (2011-04-01)

Biological, immunological and functional properties of two novel multi-variant chimeric recombinant proteins of CSP antigens for vaccine development against Plasmodium vivax infection
by: Shabani, S, et al.
Published: (2017)

Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge
by: de Camargo, T, et al.
Published: (2018)

CLINICAL EVALUATION OF NEW VIRAL VECTORED VACCINES TARGETING THE PLASMODIUM FALCIPARUM BLOOD-STAGE ANTIGENS; MSP1 AND AMA1
by: Sheehy, S, et al.
Published: (2011)

Genetic polymorphism in msp-2, ama-1 and csp genes in Plasmodium falciparum field isolates from north and north-western India
by: Umar Farooq, et al.
Published: (2009-06-01)

Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02.
by: Meta Roestenberg, et al.
Published: (2008-01-01)

Effective and cheap removal of leukocytes and platelets from Plasmodium vivax infected blood.
by: Sriprawat, K, et al.
Published: (2009)

Cryopreserved Plasmodium vivax and cord blood reticulocytes can be used for invasion and short term culture.
by: Borlon, C, et al.
Published: (2012)

Cryopreserved Plasmodium vivax and cord blood reticulocytes can be used for invasion and short term culture
by: Borlon, C, et al.
Published: (2012)

Genetic diversity in new members of the reticulocyte binding protein family in Thai Plasmodium vivax isolates
by: Kosaisavee, V, et al.
Published: (2012)

Asian G6PD-Mahidol reticulocytes sustain normal Plasmodium vivax development
by: Bancone, G, et al.
Published: (2017)

Correction: Colorimetric Detection of Plasmodium vivax in Urine Using MSP10 Oligonucleotides and Gold Nanoparticles.
by: Yossef Alnasser, et al.
Published: (2016-11-01)

Genotyping of <i>MSP3</i>β gene in Indian <i>Plasmodium vivax</i>
by: Purva Gupta, et al.
Published: (2013-08-01)

Field-based flow cytometry for ex vivo characterization of Plasmodium vivax and P. falciparum antimalarial sensitivity.
by: Russell, B, et al.
Published: (2013)

Rheopathologic Consequence of Plasmodium vivax Rosette Formation.
by: Rou Zhang, et al.
Published: (2016-08-01)